Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
2.820
+0.030 (1.06%)
Apr 21, 2026, 4:08 PM HKT
20.51% (1Y)
| Market Cap | 7.25B +4.1% |
| Revenue (ttm) | 763.16M -3.3% |
| Net Income | -175.20M |
| EPS | -0.17 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.03 (1.14%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 789,000 |
| Average Volume | 1,743,900 |
| Open | 2.850 |
| Previous Close | 2.820 |
| Day's Range | 2.810 - 2.900 |
| 52-Week Range | 2.330 - 5.290 |
| Beta | 0.19 |
| RSI | 41.42 |
| Earnings Date | Mar 30, 2026 |